Trial intelligence / Profile preview

Multi-organ Imaging of Microvascular and Metabolic Function

NCT07604207Phase 1Not yet recruiting

Sponsor
Massachusetts General Hospital
Start
Jan 2027
Primary completion
Jul 2031
01

Overview

Phase 1, open-label, single-arm trial, sponsored by Massachusetts General Hospital. Primary endpoint: Blood flow responses. Planned start Jan 2027; status: not yet recruiting.

Beyond the preview

Go deeper on NCT07604207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07604207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call